After treatment initiation and dose increases, patients should be observed carefully for signs and symptoms of pancreatitis (including persistent severe abdominal pain, sometimes radiating to the back and which may or may not be accompanied by vomiting)
This is why we view it as one component of a larger, personalized health strategy designed for lasting performance, not just a temporary fix
Patients with a history of sensitivity to cobalamin should discuss this with their provider before starting
In these cases, a maintenance injection is often needed every 2-3 months to keep levels stable, as the body cant consistently source it otherwise
Yes, you can stack tirzepatide with 5-amino-1MQ in research settings
Your practitioner will measure your progress and refine your plan along the way